Xencor Adds Board Member

Monrovia-based biopharmaceuticals developer Xencor announced this morning that it has appointed Yujiro S. Hata to its board of directors. Hata is currently the Chief Operating Officer at FLX Bio, and he previously was Chief Operating Officer at Flexuss Biosciences. Hata has also served at Onyx Pharmaceukticals, Enata Pharmaceuticals, Gneome Therapeutics Corporation, McKinsey and Company, and ImClone Systems.